deflazacort has been researched along with pamidronate in 2 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (pamidronate) | Trials (pamidronate) | Recent Studies (post-2010) (pamidronate) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 2,220 | 368 | 444 |
| Protein | Taxonomy | deflazacort (IC50) | pamidronate (IC50) |
|---|---|---|---|
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 1.0745 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Reilly, CW; Schaeffer, EK; Singh, A | 1 |
2 other study(ies) available for deflazacort and pamidronate
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pamidronate; Pregnenediones; Quality of Life; Retrospective Studies; Risk Factors; Spinal Fractures; Time Factors; Walking | 2018 |